Effects of orally administered galacto-oligosaccharides on immunological parameters in foals: a pilot study.
Authors: Vendrig Johannes Cornelis, Coffeng Luc Edgar, Fink-Gremmels Johanna
Journal: BMC veterinary research
Summary
# Editorial Summary: Galacto-oligosaccharides and foal immunity Early-life bacterial infections remain a significant challenge in foal health, particularly during the critical period when passive immunity from colostrum wanes and active immune competence develops. Cornelis and colleagues conducted a pilot trial administering a commercial galacto-oligosaccharide (GOS) supplement to ten pony foals (six treated, four controls) from birth through four weeks of age, with immunological monitoring continuing for a further ten weeks, aiming to establish whether GOS could replicate the prebiotic and immune-modulating effects already demonstrated in human infants and laboratory animals. The study assessed immunological parameters across the treatment and follow-up periods to identify whether oral GOS supplementation influenced foal immune function during this vulnerable developmental window. Whilst limited in scale, this represents the first in vivo investigation of GOS efficacy in equine species and provides preliminary evidence that could inform future large-scale trials examining whether prebiotic supplementation might reduce neonatal infection rates or enhance long-term immune tolerance in young horses. Given the established benefit of GOS in other species and the significant morbidity associated with early-life infections in foals, findings from this pilot warrant expansion into controlled studies examining clinical outcomes, optimal dosing protocols, and whether effects persist through weaning and into ridden life.
Read the full abstract on PubMed
Practical Takeaways
- •This pilot provides preliminary evidence that GOS supplementation during the critical early neonatal period may be a practical, non-invasive strategy to support foal immune development alongside colostrum optimization
- •Small sample size (10 foals total) means results are exploratory only—larger controlled trials needed before implementing GOS as standard management practice
- •If positive effects are confirmed in future studies, GOS could offer a cost-effective nutritional intervention during the vulnerable first weeks when foals are most susceptible to bacterial infections
Key Findings
- •Galacto-oligosaccharide supplementation was administered to 6 pony foals during the first 4 weeks of life with 4 control foals for comparison
- •Study design included 14-week follow-up period (4 weeks treatment + 10 weeks post-treatment monitoring)
- •Pilot study investigated prebiotic and immunomodulating effects of orally administered GOS in foals, with no prior in vivo equine studies available